Pfizer's second-quarter earnings tumble, still tops expectations
July 28, 2015 at 11:04 AM EDT
Pfizer's second-quarter earnings fell 10%, as the largest U.S. drugmaker absorbed revenue hits from a stronger U.S. dollar and the loss of patent protection for some key products. But the maker of... To view the full story, click the title link.
